Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis

Objective To review the literature on the use of inhaled nitric oxide to treat acute lung injury/acute respiratory distress syndrome (ALI/ARDS) and to summarise the effects of nitric oxide, compared with placebo or usual care without nitric oxide, in adults and children with ALI or ARDS. Design Systematic review and meta-analysis. Data sources Medline, CINAHL, Embase, and CENTRAL (to October 2006), proceedings from four conferences, and additional information from authors of 10 trials. Review methods Two reviewers independently selected parallel group randomised controlled trials comparing nitric oxide with control and extracted data related to study methods, clinical and physiological outcomes, and adverse events. Main outcome measures Mortality, duration of ventilation, oxygenation, pulmonary arterial pressure, adverse events. Results 12 trials randomly assigning 1237 patients met inclusion criteria. Overall methodological quality was good. Using random effects models, we found no significant effect of nitric oxide on hospital mortality (risk ratio 1.10, 95% confidence interval 0.94 to 1.30), duration of ventilation, or ventilator-free days. On day one of treatment, nitric oxide increased the ratio of partial pressure of oxygen to fraction of inspired oxygen (PaO2/FiO2 ratio) (13%, 4% to 23%) and decreased the oxygenation index (14%, 2% to 25%). Some evidence suggested that improvements in oxygenation persisted until day four. There was no effect on mean pulmonary arterial pressure. Patients receiving nitric oxide had an increased risk of developing renal dysfunction (1.50, 1.11 to 2.02). Conclusions Nitric oxide is associated with limited improvement in oxygenation in patients with ALI or ARDS but confers no mortality benefit and may cause harm. We do not recommend its routine use in these severely ill patients.

[1]  D. Payen,et al.  A European survey of the use of inhaled nitric oxide in the ICU , 1998, Intensive Care Medicine.

[2]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[3]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[4]  A. Artigas,et al.  Report of the American-European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordination , 1994, Intensive Care Medicine.

[5]  U. Ruttimann,et al.  Efficiency of intensive care. A comparative analysis of eight pediatric intensive care units. , 1987, JAMA.

[6]  J F Murray,et al.  An expanded definition of the adult respiratory distress syndrome. , 1988, The American review of respiratory disease.

[7]  W. G. Cochran.  The combination of estimates from different experiments. , 1954 .

[8]  J. Clemmesen.  On the age distribution of cancer of the lung. , 1954, Acta - Unio Internationalis Contra Cancrum.

[9]  R. Furchgott.  The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide. , 1996, JAMA.

[10]  T C Chalmers,et al.  A comparison of statistical methods for combining event rates from clinical trials. , 1989, Statistics in medicine.

[11]  R. Goris,et al.  Multiple-organ failure. Generalized autodestructive inflammation? , 1985, Archives of surgery.

[12]  D. Schoenfeld,et al.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[13]  R. Blantz,et al.  Acute renal failure: is nitric oxide the bad guy? , 2002, Antioxidants & redox signaling.

[14]  C. Chant,et al.  Pharmacotherapy of acute respiratory distress syndrome , 2002, Expert opinion on pharmacotherapy.

[15]  C. Bode,et al.  Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo. , 1998, Circulation.

[16]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[17]  M. Matthay,et al.  The acute respiratory distress syndrome. , 1996, The New England journal of medicine.

[18]  G. Guyatt,et al.  Survey of interventions for the prevention and treatment of acute respiratory distress syndrome* , 2004, Critical care medicine.

[19]  B Eiseman,et al.  Multiple organ failure. , 1977, Surgery, gynecology & obstetrics.

[20]  L. Hudson,et al.  Causes of Mortality in Patients with the Adult Respiratory Distress Syndrome , 1985, The American review of respiratory disease.

[21]  D. Bohn,et al.  Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults. , 2003, The Cochrane database of systematic reviews.

[22]  T. Evans,et al.  Inhaled nitric oxide therapy in adults. , 2005, The New England journal of medicine.

[23]  P. Kubes,et al.  Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Jacob Cohen,et al.  The Equivalence of Weighted Kappa and the Intraclass Correlation Coefficient as Measures of Reliability , 1973 .

[25]  Joseph Beyene,et al.  Meta-Analysis: Low-Dose Dopamine Increases Urine Output but Does Not Prevent Renal Dysfunction or Death , 2005, Annals of Internal Medicine.

[26]  A. Arroliga,et al.  Emerging systemic pharmacologic approaches in acute respiratory distress syndrome. , 2003, Respiratory care clinics of North America.

[27]  Peter M. Suter,et al.  Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. , 1999, JAMA.

[28]  M. Matthay,et al.  Treatment of ARDS. , 2001, Chest.

[29]  R. McIntyre,et al.  Thirty years of clinical trials in acute respiratory distress syndrome , 2000, Critical care medicine.

[30]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[31]  S. Mehta,et al.  High-frequency oscillatory ventilation and adjunctive therapies: Inhaled nitric oxide and prone positioning , 2005, Critical care medicine.

[32]  Arthur S Slutsky,et al.  Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. , 1999, JAMA.

[33]  T. Evans,et al.  The pulmonary physician in critical care c 9: Non-ventilatory strategies in ARDS , 2002 .

[34]  D. Bohn,et al.  Inhaled Nitric Oxide for Acute Hypoxic Respiratory Failure in Children and Adults: A Meta-analysis , 2003, Anesthesia and analgesia.

[35]  G. Bernard,et al.  Acute respiratory distress syndrome. Potential pharmacologic interventions. , 2000, Clinics in chest medicine.

[36]  A. Ishizaka,et al.  Pharmacology of acute lung injury. , 2002, Pulmonary pharmacology & therapeutics.